INTRODUCTION
Cell surface glycoproteins, im portant in varied im m u nological processes are known to act as receptors for several viruses. The major group of non-enveloped rhinoviruses utilize the adhesion molecule ICAM-1 (Greve etal. 1989; Staunton al. 1989) , whereas the Herpes virus and Epstein-Barr virus (EBV) infect Bcells after binding to complement receptor 2 (CR2) (Weis et al. 1988) , and the prim ate lentiviruses, hum an and simian immunodeficiency viruses (H IV and SIV) use the CD4 antigen (Dalgleish et 1984; Klatzm an et al. 1984; Sattentau al. 1988 ). Binding of H IV to CD4 results in conformational changes in the virion glycoproteins (Sattentau & Moore 1991) and in CD4 (Walker et 1992) . Structural alterations in virion gpl20 and gp41 are probably essential to induce a short hydrophobic sequence (fusion domain) at the N-terminal of gp41 to insert into the lipid membrane at the cell surface. This insertion initiates virion and cell membrane fusion. Thus H IV is doubly dependent on CD4 for cell entry; first to attach to the cell surface and then for events leading to fusion.
This article reviews whether cell surface molecules other than CD4 are required for or can influence H IV entry into cells.
IS CD4 SUFFICIENT FOR ENTRY?
Evidence presented by M addon et al. (1986) seven years ago suggested there were additional require ments to CD4 for H IV entry. Expression of CD4 on human but not mouse cells conferred susceptibility to H IV entry. This result suggested that there might be a factor or second component to the receptor, expressed on human cells but absent on mouse cells. If this is the case, then hybrid or heterokaryon cells made from mouse and hum an cells should perm it H IV entry if positive for hum an CD4. Studies with such m ousehum an hybrids initially gave ambiguous results. W einer et al. (1991) were able to infect several hybrids and suggested that additional factors needed for H IV entry m apped to chromosome 13, 14, 20 or 21. In contrast, Tersmette et al. (1989) were unable to detect HIV-1 entry in several hybrids, one of which appeared to contain all hum an chromosomes. As well as spontaneously losing hum an chromosomes, its pos sible that m ouse-hum an hybrids stop expressing hum an genes. Thus W einer's positive results may be more meaningful than Tersm ette's negative data. Short-term cultures of anim al-hum an heterokaryons prepared by Drajic et al. (1992) and Broder et al. (1993) have provided more convincing evidence. Drajic used virons bearing H IV envelope glyco proteins and containing an M LV based genome constructed to include an expressible (3-galactosidase gene. Entry was detected by adding a colour-forming galactosidase substrate to fixed virus treated cells. HIV-resistant C D 4+ mouse 3T3 cells and CD4-hum an HeLa cells were fused by polyethylene glycol and resulting heterokaryons became sensitive to HIV-1 entry. Similar evidence has also been provided by Hoxie el al. (1988) who described a hybridom a cell line (CEMX174) sensitive to infection by certain SIV strains, but prepared from resistant parents; CD4 + CEM T -and C D 4-B721.174 B-cells. Thus several reports present evidence that an additional factor can be provided to render resistant CD4-expressing cells permissive for H IV and SIV entry.
A SERINE PROTEASE IS A CANDIDATE SECOND COMPONENT
A serine protease, tryptase T L 2 has been implicated as a candidate second component. Tryptase T L 2 is a membrane bound serine esterase (Hattori et al. 1989) (Kido et al. 1991) . A conserved tryptic cleavage site on V3 can be shown to be cut by proteases in vitro (Clements et al. 1991; Schulz el al. 1993) , and is thought to be the target for tryptase TL2 . Convincing proof that tryptase T L 2 is required for HIV-1 entry awaits cloning and construction of vectors for its expression. It will be interesting to ascertain whether transfection and expression of tryp tase TL2 will render resistant C D 4+ cell types (e.g. U87/CD4, see below) sensitive to HIV-1 entry.
DIFFERENT REQUIREMENTS FOR DIFFERENT VIRUS TYPES
We expressed human CD4 on a panel of CD4-negative human and non-human cell types. Although all cells expressing CD4 bound recombinant gpl20, only CD 4+ human cells were susceptible to HIV-1 infection (table 1) (Clapham al. 1991) . Each cell type was tested for sensitivity to infection by vesicular stomatitis virus (VSV) pseudotypes of HIV . VSV pseudotypes are mixed virions containing the nucleocapsid of VSV but bearing the envelope glycoproteins of HIV. They require a functional H IV receptor for entry, however the highly cytopathic VSV genome directs replication and a lytic plaque forms during overnight incubation. VSV pseudotypes thus provide a plaque assay specific for H IV entry. Only CD4 + human cells that permitted HIV-1 replication, were sensitive to VSV pseudotype infection. This result confirmed that there was a cell surface restraint to HIV-1 entry on C D 4+ non-human cell types. In contrast, many C D 4+ non-human cells were sensitive to HIV-2 and SIV entry. Cells derived from rhesus monkey, african green monkey, cat, mink and rabbits (but not rat or mouse) supported HIV-2 and SIV induced fusion and at least some replication. These results indicate that HIV-2 and SIV have different requirements for entry compared with HIV-1 (table 1) A. M cKnight, unpublished observations) . We observed similar differences on a hum an glioma cell line, U87. C D 4+ U87 cells restricted entry by HIV-1 strains (also reported by Chesebro et al. 1990 ), but were permissive for HIV-2 and SIV fusion (table 2 and figure 1) and replication. Several groups (including ourselves) have observed that SIV strains (SM, MAC and AGM) fail to infect or fuse certain C D 4+ hum an cell lines that are fully permissive to HIV-1 and HIV-2 (Hoxie et al. 1988; Koenig et al. 1989) . Table 2 and figure 1 show that although C D 4+ hum an RD rhabdom yosarcoma cells were sensitive to fusion by all HIV-1 and HIV-2 strains tested they resisted each SIV isolate tested. This lack of cell fusion seems to indicate an entry restraint in our system, however one study using chimeric SIV/HIV-1 viruses showed that sequences in the 5' half of the genome and not envelope sequences determined the lack of infection by S IV agm in the hum an T cell line, M T-4 (Shibata & Adachi 1992) . Although these experiments rely on the lack of entry on C D 4+ cells to imply extra requirements, they suggest that HIV-1, HIV-2 and SIV laboratory strains use distinct cell surface molecules during entry of hum an cells but after binding CD4.
IMPORTANCE OF CELL SURFACE EVENTS IN DETERMINING TROPISMS IN VIVO
Several reports have mapped determ inants of tropism to gpl20 envelope sequences of HIV-1. Some reports show that gpl20 envelope sequences that include the V3 loop can determine m acrophage or T cell tropism (Cann et al. 1992; O 'Brien et al. 1990; Hwang et al. 1991; Shioda et al. 1991; Westerfelt et al. 1991 Westerfelt et al. , 1992 Bergeron et al. 1992) and Takeuchi et al. (1991) demonstrated that a single point m utation in V3 conferred the capacity of a Japanese isolate to infect CD4 + brain cells. O ther studies suggest that envelope sequences other than V3 can affect tropism (Cordonnier et al. 1989; Bergeron et al. 1992; Westerfelt et al. 1992; Boyd et al. 1993) . For instance, Westerfelt et a/. (1992) implicated three amino acid changes in VI or V2 to affect macrophage infection and Boyd et al. (1993) showed that a single amino acid change in VI expanded the T cell tropism of a primary strain to two established CD4 + T cell lines. Since sequences in V I, V2 and V3 are not part of the CD4 binding domain, and assuming they don't influence post fusion events, these findings also suggest that gpl20 interacts with specific cell surface molecules other than CD4 to determine tropism. It is difficult to estimate to what extent cell surface events determine tropism, but it does not seem absolute. Cheng-Meyer et al. (1991) reported that tat sequences determined the capacity of an HIV-1 strain to replicate in Hut78 cells and Fenyo et al. (1988) showed that many primary HIV-1 strains replicated in Ju rkat cells if transfected recombinant tat was expressed. Recently, Potash et al. (1992) found that the capacity of a range of primary isolates to fuse with macrophages did not correlate with infectivity. Poly merase chain reaction (pcr) analysis of reverse tran scription suggested an early post-fusion restriction for several isolates. We have also noted that several T cell line tropic viruses that are unable to replicate in primary macrophage cultures, are competent for fusion in syncytium inducing assays (figure 2). PCR analysis of reverse transcripts in this system suggests an early post-fusion restriction in replication (G. Simmons, unpublished results). However, differences in envelope-mediated cell-to-cell fusion and virion-tocell fusion could explain our results.
ALTERNATIVE RECEPTORS FOR HIV?
Few viruses have been described that can use more than one receptor to attach to cells. One example is mouse hepatitis virus (mhv), a coronavirus which attaches to several members of a family of related carcinoembryonic antigens (cea) (Yokomori & Lai 1992; Dveksler et al. 1993) , but probably to the same binding site.
Many groups have reported that HIV-1 strains can infect several hum an cell types that do not express CD4 (reviewed by Clapham 1991) . Generally, this type of infection is extremely inefficient, requiring a large dose of input virus to achieve infection of only a small number of cells. Harouse et al. (1991) demonstrated that galactocereboside acts as a receptor for HIV-1 infection of neuronal cell types and Yahi et al. (1992) showed the figure 2 Primary macrophages fused after overnight co-cultivation with H9 cells producing T cell line tropic HIV/RF.
same (or a related) molecule is a receptor for infection of the colon carcinoma cell line HT-29. Curtis et al. (1992) were able to clone a gene encoding a mem brane-associated C-type lectin that bound to gpl20 to high affinity. This molecule however, did not serve as a receptor for infection when expressed on CD4-negative HeLa cells. The double requirement of CD4 for H IV cell attachm ent and subsequent conformational alterations leading to fusion events may limit the probability that CD4-independent variants will emerge. Thus, although gpl20 can efficiently bind to other cell surface mole cules, e.g. to galactocereboside and to Curtis' C-type lectin, it is unlikely that either of these molecules can induce the structural alterations in the virion glycopro teins needed for fusion.
Although it is possible that CD4-independent HIV-1 strains exist in vivo, there is little evidence that thistype of entry plays a role in pathogenesis. In situ hybridiza tion and immunochemistry suggest that infected cells in the peripheral blood, lymph, skin, gut, lung and brain are restricted to cells likely to express CD4. These cells include T lymphocytes, monocytes, macrophages, dendritic and microglial cells (see review by Clapham 1991) .
In contrast to HIV-1, we have described HIV-2 strains that infect a restricted number of CD4-negative human cell types (Clapham et al. 1992) . These HIV-2 isolates were capable of inducing cell to cell fusion in RD rhabdomyosarcoma cells as well as Daudi and Raji B-cell lines. Although only some HIV-2 strains effi ciently induced syncytia in RD or Daudi cells, soluble CD4 surprisingly enhanced cell fusion and even induced syncytium-negative viruses to fuse. The cell surface molecules contributing to this process are at present obscure, but are likely to involve at least one alternative receptor. We do not know if HIV-2 variants with an increased capacity to infect cells lacking CD4 exist in vivo. Such variants would be expected to infect an expanded range of cells, but few studies have yet been done to examine cell types infected by HIV-2 in the tissues of infected individuals. We are currently investigating whether prim ary HIV-2 isolates can be made that propagate in appropriate CD4-negative cells.
ALTERNATIVE RECEPTORS AND CD4-DEPENDENT ENTRY
It is conceivable that an accessory cell surface mole cule required during CD4-dependent infection could also act as a CD4-independent receptor. In this situation an H IV strain would acquire the capacity to bind directly to the accessory molecule, bypassing CD4 entirely. If this was the case for the H IV-2 alternative receptor, then CD4-negative cells that resist HIV-2 entry, might be expected also to resist infection when CD4 is expressed. It has not been possible to test this premise on hum an cells as cells that lack CD4, permit low efficiency HIV-2 infection. As already discussed however, many non-hum an cells transfected with and expressing hum an CD4 are permissive to HIV-2 entry and replication (table 1) . These cells must express all accessory cell surface molecules required for HIV -2 entry. The CD4-negative parental counterparts to these cells are completely resistant to all HIV-2 strains tested, indicating (at least for these non-human cells) that accessory mole cules do not act as alternative receptors.
INVOLVEMENT OF ADHESION MOLECULES IN HIV-1 INFECTION AND FUSION
Several studies have shown that monoclonal anti bodies (mAbs) to the /Lchain of LFA-1 inhibit HIV-1 syncytia formation (Busso et al. 1991; Hildreth et al. 1989; Pantaleo et al. 1991; Vermot-Desroches et al. 1991) . Vermot-Desroches et al. (1991) showed that inhibition was epitope dependent and that antibody interaction with LFA-1 expressed on the CD4 + target cell was crucial for inhibition. The ligand for LFA-1 in HIV-1 induced syncytia is not clear, although two groups have reported weak inhibition with ICAM-1 antibodies (Vermot-Desroches al. 1991; G ruber et al. 1991) . Thus it is likely that LFA-1 directed cell conjugates must first form before efficient HIV-1 induced cell to cell fusion can occur. There is also controversy over whether LFA-1 mAbs inhibit HIV-1 infection by cell free virus. Kalter al. (1991) and Hansen et al. (1991) both reported inhibition of cell free HIV-1 infection by LFA-1 mAbs; K alter et al. on macrophages and Hansen et al. on T cells. Pantaleo et al. (1991) , however showed that Tlymphocytes from patients deficient for LFA-1 were efficiently infected by HIV-1 but failed to form syncytia.
CONCLUSIONS
Although HIVs and SIVs use CD4 to attach to cells, there are clearly other cell surface molecules that can influence entry into cells. It is likely that at least one molecule additional to CD4 is essential before the virion and cellular membranes can fuse. The precise nature and function of this molecule is at present unknown. Other cell surface molecules can act as alternative receptors, either for attachm ent only (e.g.
Curtis' lectin-like receptor) or for complete entry (e.g. our alternative HIV-2 receptor). The extent of influence that these alternative receptors have on CD4-dependent entry is not known. Receptors for ligands that also bind H IV virions may also affect attachm ent. Examples include CR2, the receptor for C lq that specifically interacts with a conserved region on gp41 (Ebenbichler et al. 1991) , as well as Fc receptors that bind antibody-virus conjugates. Both these events have been shown to enhance HIV-1 infectivity.
Thus, an array of cell surface molecules have been described that can influence H IV or SIV entry. Full definition and evaluation of their contribution to natural infection still awaits cloning and identification of molecules implicated in biological assays. 
